Assistance Publique - Hôpitaux de Paris: Inflammatory Bowel Diseases trials
The registry lists 13 Inflammatory Bowel Diseases studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 3No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham TransplantationNot yet recruitingNCT07477782Phase 2
- Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.Not yet recruitingNCT07172945Not applicable
- Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)Not yet recruitingNCT07167186
- Digestive Biobank for Exploring Microbiota-host InteractionsRecruitingNCT05704413
- Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF WithdrawalRecruitingNCT04997733Phase 3
- Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral DeficiencyCompletedNCT06659588
- IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®Active, not recruitingNCT05722353Not applicable
- Urinary PGE-MUM (PROSTAGLANDIN E-MAJOR URINARY METABOLITE) as Inflammatory Marker in Chronic Inflammatory Bowel DiseaseCompletedNCT05171452
- Impact of Fecal Microbiota Transplantation in Ulcerative ColitisActive, not recruitingNCT03483246Phase 3
- Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel DiseaseCompletedNCT02726243
- Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel DiseaseStatus unknownNCT02693340
- Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel DiseasesCompletedNCT02020382Not applicable
- Efficacy Safety Study of Flu Vaccine in Immunodepression PatientsCompletedNCT01022749Phase 3